Madrigal Pharmaceuticals

Madrigal Reports $212.8M in Q2 Rezdiffra Sales, Expands Global Pipeline and Secures $500M Financing

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) reported strong second-quarter results, led by surging demand for Rezdiffra™, its recently launched treatment for metabolic dysfunction-associated steatohepatitis (MASH). The company also outlined …

Madrigal Reports $212.8M in Q2 Rezdiffra Sales, Expands Global Pipeline and Secures $500M Financing Read More


Ayden Dougherty

Temple Student Ayden Dougherty Gains Hands-On Industry Experience at Farmers of Salem Internship

WILMINGTON, DE — Farmers of Salem (FOS) announced the successful participation of Temple University student Ayden Dougherty in its summer internship program, highlighting the company’s continued commitment to mentoring the next …

Temple Student Ayden Dougherty Gains Hands-On Industry Experience at Farmers of Salem Internship Read More